Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP227140.RAfJiDFrhHiOpMQkUN8VUwzE09WBk5GphQl-fK3Z3lrYc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP227140.RAfJiDFrhHiOpMQkUN8VUwzE09WBk5GphQl-fK3Z3lrYc130_assertion type Assertion NP227140.RAfJiDFrhHiOpMQkUN8VUwzE09WBk5GphQl-fK3Z3lrYc130_head.
- NP227140.RAfJiDFrhHiOpMQkUN8VUwzE09WBk5GphQl-fK3Z3lrYc130_assertion description "[NY-ESO-1 is more frequently expressed in metastatic than in primary malignant melanoma and its expression is associated with thicker primary lesions and a higher frequency of metastatic disease, indicative of a worse prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227140.RAfJiDFrhHiOpMQkUN8VUwzE09WBk5GphQl-fK3Z3lrYc130_provenance.
- NP227140.RAfJiDFrhHiOpMQkUN8VUwzE09WBk5GphQl-fK3Z3lrYc130_assertion evidence source_evidence_literature NP227140.RAfJiDFrhHiOpMQkUN8VUwzE09WBk5GphQl-fK3Z3lrYc130_provenance.
- NP227140.RAfJiDFrhHiOpMQkUN8VUwzE09WBk5GphQl-fK3Z3lrYc130_assertion SIO_000772 17625806 NP227140.RAfJiDFrhHiOpMQkUN8VUwzE09WBk5GphQl-fK3Z3lrYc130_provenance.
- NP227140.RAfJiDFrhHiOpMQkUN8VUwzE09WBk5GphQl-fK3Z3lrYc130_assertion wasDerivedFrom lhgdn-20090331 NP227140.RAfJiDFrhHiOpMQkUN8VUwzE09WBk5GphQl-fK3Z3lrYc130_provenance.
- NP227140.RAfJiDFrhHiOpMQkUN8VUwzE09WBk5GphQl-fK3Z3lrYc130_assertion wasGeneratedBy ECO_0000203 NP227140.RAfJiDFrhHiOpMQkUN8VUwzE09WBk5GphQl-fK3Z3lrYc130_provenance.